Literature DB >> 2263610

Cell line-specific differences in the control of cell cycle progression in the absence of mitosis.

A L Kung1, S W Sherwood, R T Schimke.   

Abstract

This paper reports that there are major differences between mammalian cell lines in the propensity to progress into subsequent cell cycles when mitosis is inhibited with agents that disrupt the assembly of the mitotic spindle apparatus (Colcemid, nocodazole, and taxol). Human HeLa S3 cells, which represent one extreme, remain arrested in mitosis, with elevated levels of cyclin B and p34cdc2 kinase activity. In Chinese hamster ovary cells, at the other extreme, the periodic rise and fall of cyclin B levels and p34cdc2 kinase activity is only transiently inhibited in the absence of mitosis. The cells progress into subsequent cell cycles, without dividing, resulting in serial doublings of cellular DNA content. In general, the propensity to progress into subsequent cell cycles in the absence of mitosis appears to be species related, such that human cell lines remain permanently blocked in a mitotic state, whereas rodent cell lines are only transiently inhibited when spindle assembly is disrupted. We interpret these results to indicate that in mammalian cell lines there exists a checkpoint which serves to couple cell cycle progression to the completion of certain karyokinetic events. Furthermore, either such a checkpoint exists in some cell lines but not in others or the stringency of the control mechanism varies among different cell lines.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2263610      PMCID: PMC55210          DOI: 10.1073/pnas.87.24.9553

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  11 in total

Review 1.  Checkpoints: controls that ensure the order of cell cycle events.

Authors:  L H Hartwell; T A Weinert
Journal:  Science       Date:  1989-11-03       Impact factor: 47.728

Review 2.  Dominoes and clocks: the union of two views of the cell cycle.

Authors:  A W Murray; M W Kirschner
Journal:  Science       Date:  1989-11-03       Impact factor: 47.728

3.  Mutation of fission yeast cell cycle control genes abolishes dependence of mitosis on DNA replication.

Authors:  T Enoch; P Nurse
Journal:  Cell       Date:  1990-02-23       Impact factor: 41.582

Review 4.  Identifying tumor suppressor genes in human colorectal cancer.

Authors:  E J Stanbridge
Journal:  Science       Date:  1990-01-05       Impact factor: 47.728

Review 5.  Driving the cell cycle: M phase kinase, its partners, and substrates.

Authors:  B Lewin
Journal:  Cell       Date:  1990-06-01       Impact factor: 41.582

6.  Isolation of a human cyclin cDNA: evidence for cyclin mRNA and protein regulation in the cell cycle and for interaction with p34cdc2.

Authors:  J Pines; T Hunter
Journal:  Cell       Date:  1989-09-08       Impact factor: 41.582

7.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

8.  S phase-specific synthesis of dihydrofolate reductase in Chinese hamster ovary cells.

Authors:  B D Mariani; D L Slate; R T Schimke
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

9.  Mutations in alpha- and beta-tubulin affect spindle formation in Chinese hamster ovary cells.

Authors:  I Abraham; M Marcus; F Cabral; M M Gottesman
Journal:  J Cell Biol       Date:  1983-10       Impact factor: 10.539

10.  p34cdc2 is located in both nucleus and cytoplasm; part is centrosomally associated at G2/M and enters vesicles at anaphase.

Authors:  E Bailly; M Dorée; P Nurse; M Bornens
Journal:  EMBO J       Date:  1989-12-20       Impact factor: 11.598

View more
  61 in total

1.  Visualizing the spindle checkpoint in Drosophila spermatocytes.

Authors:  E Rebollo; C González
Journal:  EMBO Rep       Date:  2000-07       Impact factor: 8.807

2.  Lack of synchrony among multiple nuclei induces partial DNA fragmentation in V79 cells polyploidized by demecolcine.

Authors:  K Fujikawa-Yamamoto; C Ohdoi; H Yamagishi; Z P Zong; M Murakami; N Yamaguchi
Journal:  Cell Prolif       Date:  1999-12       Impact factor: 6.831

3.  Mast, a conserved microtubule-associated protein required for bipolar mitotic spindle organization.

Authors:  C L Lemos; P Sampaio; H Maiato; M Costa; L V Omel'yanchuk; V Liberal; C E Sunkel
Journal:  EMBO J       Date:  2000-07-17       Impact factor: 11.598

4.  Control of microtubule dynamics by oncoprotein 18: dissection of the regulatory role of multisite phosphorylation during mitosis.

Authors:  N Larsson; U Marklund; H M Gradin; G Brattsand; M Gullberg
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

5.  Tetraploid state induces p53-dependent arrest of nontransformed mammalian cells in G1.

Authors:  P R Andreassen; O D Lohez; F B Lacroix; R L Margolis
Journal:  Mol Biol Cell       Date:  2001-05       Impact factor: 4.138

6.  Aneugenic activity of Op18/stathmin is potentiated by the somatic Q18-->e mutation in leukemic cells.

Authors:  Per Holmfeldt; Kristoffer Brännström; Sonja Stenmark; Martin Gullberg
Journal:  Mol Biol Cell       Date:  2006-04-19       Impact factor: 4.138

7.  Paclitaxel-dependent cell lines reveal a novel drug activity.

Authors:  Anutosh Ganguly; Hailing Yang; Fernando Cabral
Journal:  Mol Cancer Ther       Date:  2010-10-26       Impact factor: 6.261

8.  A ubiquitous beta-tubulin disrupts microtubule assembly and inhibits cell proliferation.

Authors:  Rajat Bhattacharya; Fernando Cabral
Journal:  Mol Biol Cell       Date:  2004-04-30       Impact factor: 4.138

9.  Inhibition of cell migration and cell division correlates with distinct effects of microtubule inhibiting drugs.

Authors:  Hailing Yang; Anutosh Ganguly; Fernando Cabral
Journal:  J Biol Chem       Date:  2010-08-09       Impact factor: 5.157

Review 10.  Spindle checkpoint function and cellular sensitivity to antimitotic drugs.

Authors:  Hiroshi Y Yamada; Gary J Gorbsky
Journal:  Mol Cancer Ther       Date:  2006-12       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.